Comparative pharmacokinetic study of idarubicin and daunorubicin in leukemia patients-Reference-Cited by-同舟云学术

Comparative pharmacokinetic study of idarubicin and daunorubicin in leukemia patients

Published:1992-03 Issue:2 Volume:10 Page:111-116
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol. Oncol.

Author:

Robert J.,Rigal-Huguet F.,Hurteloup P.

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference20 articles.

1. Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia

2. Extraction of Anthracyclines from Biological Fluids for HPLC Evaluation

3. Liquid Chromatographic Analysis of Adriamycin and Metabolites in Biological Fluids

4. Pharmacokinetic concepts basic to cancer chemotherapy. In: , , eds. Pharmacokinetics of Anticancer Agents in Humans. Amsterdam, New York, Oxford: Elsevier, 1983: 1–28.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiotoxicity in Pediatric AML;Pediatric Oncology;2024

2. Rationale and design of the Children's Oncology Group study AAML1831 integrated cardiac substudies in pediatric acute myeloid leukemia therapy;Frontiers in Cardiovascular Medicine;2023-12-01

3. Chemotherapy;Medicines for Cancer;2023

4. Is there scope for better individualisation of anthracycline cancer chemotherapy?;British Journal of Clinical Pharmacology;2020-11-30

5. A highly sensitive UHPLC-MS/MS method for urine biological monitoring of occupational exposure to anthracycline antineoplastic drugs and routine application;Journal of Chromatography B;2020-11